Hospitals to Remain the Largest End-Users of Normal Balloon Catheter Market
Rockville, MD -- (SBWIRE) -- 05/10/2019 -- Rising prevalence of patients with end stage renal disease, and growth in interventional cardiology will facilitate the utilization of the normal balloon catheters. Normal balloon catheter manufacturers are focusing on the development of cost-effective and more efficient solutions. This Fact.MR report analyzes the expansion of global normal balloon catheter market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022 With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for normal balloon catheter manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided
Normal balloon catheter, an innovative medical device, comprises a catheter and a guidewire that is inserted into femoral artery in the legs, or, sometimes into radial artery in arms for treating constricted blood vessels. Generally normal balloon catheter is utilized for preventing blood vessel constriction, which is caused by atherosclerosis, i.e. deposition of the lipid substances in blood vessels.
With respect to end-users, normal balloon catheter in cardiac laboratories shows promising expansion in the ensuing period. However, heavy cost associated with angioplasty procedures dent the growth of the market for normal balloon catheter. In addition, peril of infection and artery collapse linked with balloon catheterization does not augur well with the growth of normal balloon catheter market.
Request Sample Here:
Europe to Account for Largest Revenue Share of the Global Normal Balloon Catheter Market
Europe is projected to be the largest market for normal balloon catheter during 2017 to 2022, in terms of revenue. Sales of normal balloon catheter in Europe will hold the largest revenue share of the market over the forecast period. In addition, normal balloon catheter sales in Asia-Pacific excluding Japan (APEJ) are expected to exhibit the fastest expansion through 2022. In contrast, the market in North America is anticipated to register the lowest CAGR through 2022.
Browse Full report with TOC:
The surge in interventional cardiology has been facilitating the utilization of normal balloon catheters. Moreover, there is a rise in prevalence of patients affected with the end stage renal disease. The number of patients seeking for renal replacement therapy has also increased. Leading manufacturers of normal balloon catheters are developing efficient and cost-effective solutions. These incidences might influence growth of the global normal balloon catheter market in the upcoming years. In contrast, costs of angioplasty procedures are very high, coupled with the risks such as artery collapse and infection related to balloon catheterization, which in turn will impede growth of the market.
The report also focuses on the epidemiology and product mapping behavior on the basis of region. The report also includes average pricing analysis and sheds light on supply chain. Assessment of the normal balloon catheter market incorporates provision of relevant market numbers and regional assessment of major factors. The report also includes regional and country-wise assessment.
A robust research methodology has been adopted for the forecast and assessment on the normal balloon catheter market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The market size of the normal balloon catheter is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.
Nylon to be Sought-after among Manufacturers of Normal Balloon Catheters
Based on raw material, nylon will remain sought-after among manufacturers of normal balloon catheters. Approximately half market share will be held by sales of nylon in the market during the forecast period. In addition, sales of polyurethane in the global market is expected to exhibit a relatively higher CAGR than that of nylon through 2022.
Normal Balloon Catheter Market: Competitive Landscape
Prominent market players being instrumental for the growth of the normal balloon catheter market are profiled and assessed on the basis of company overview, financial overview, product offering, recent development, key differentiators and strategies. The report also includes SWOT analysis as well as gives insights on normal balloon catheter market indication list and the normal balloon catheter market indication sales data and key financials.
Key players profiled in Fact.MR's report include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Meril Life Sciences Pvt. Ltd., Hexacath, Tokai Medical Products Inc., Cook Medical INC, Cordis Corporation, and BIOTRONIK SE & Co. KG.
For More Information Raise Enquiry:
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852